New treatment option for Class II Malocclusion
Official title Maxillary Segmental Distalization Using Digitally Printed Appliances
ClinicalTrials.gov ID: NCT06511219
What this study is testing
- What it's testing
- Evaluation of Maxillary Segmental Distalization Using Infrazygomatic versus Palatal Digitally Printed Skeletal Anchored Appliances.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 18. Healthy volunteers may be eligible.
You may be able to join if
- Patients age (13- 18) years.
- Full permanent dentition except third molar.
- Class II malocclusion with at least an end-on Class II molar relationship bilaterally.
- normal or short lower facial height.
You likely can't join if
- Systemic conditions that may interfere with the treatment.
- Bad habits that might jeopardize the appliance.
- Transverse discrepancy.
- Previous orthodontic treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Al Mansurah, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Al Mansurah, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.